適応型サーボ換気（ASV）が心不全患者の生存率および入院率に及ぼす影響

基本情報

NCT ID

NCT01128816

ステータス

中止

試験のフェーズ

該当なし

試験タイプ

介入

目標被験者数

732

治験依頼者名

Toronto Rehabilitation Institute

概要

Sleep Apnea (SA) is a disorder that causes pauses in breathing during sleep that expose the heart to oxygen deprivation. It is common in patients with heart failure (HF) where it is associated with increased risk of hospitalizations and death. It is not known however whether treating SA reduces these risks. This study is looking at whether a respiratory device known as Adaptive Servo Ventilation (ASV) can reduce the rate of cardiovascular hospitalizations and death in subjects with HF and SA. Study subjects will randomly receive either their regular medications OR their regular medications plus ASV. They will be followed for approximately 5 years and information relevant to their health will be collected and compared.

対象疾患

介入

依頼者（Sponsor）

実施施設 (5)